Eli Lilly stock gains after earnings rise above expectations, as COVID-19 antibodies revenue top $1 billion
[ad_1] Shares of Eli Lilly & Co. LLY, +1.03% rose 0.4% in premarket trading Thursday, after the drug giant reported fourth-quarter profit and revenue that rose above expectations, as COVID-19 antibodies revenue topped $1 billion, which was well above forecasts. Net income fell to $1.73 billion, or $1.90 a share, from $2.12 billion, or $2.32 […]
Continue Reading